Merck buys cancer therapy developer Modifi Biosciences for up to $1.3 billion
(Reuters) – Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately
(Reuters) – Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately
Investing.com — Citi analysts believe investors should consider buying Microsoft (NASDAQ:MSFT) shares following the recent pullback, citing an upside potential for the
LONDON – Fresnillo (LON:FRES) plc, a leading silver and gold mining company, reported consistent production levels in the third quarter
Lockheed Martin (NYSE: NYSE:LMT) has revealed a robust third-quarter performance for 2024, marked by a record-breaking backlog and a slight
In the third quarter of 2024, CN (Canadian National Railway (TSX:CNR) Company, ticker: CNR) reported modest financial growth and operational improvements amidst
Cadence Bank (CADE) reported a solid performance in its third-quarter 2024 earnings call on October 30, 2024, with GAAP net income reaching
Investing.com – European stock markets drifted Wednesday, with investors focusing on a deluge of third-quarter corporate earnings amid uncertainty over regional growth. At
Investing.com — Boston Scientific (NYSE:BSX) stock climbed over 1% in premarket trading Wednesday after the company raised its full-year earnings guidance, surpassing
Investing.com – AT&T (NYSE: T) reported third quarter EPS of $0.60, $0.03 better than the analyst estimate of $0.57. Revenue for the
Investing.com — With Election Day fast approaching and market volatility expected to rise, Evercore ISI analysts have assessed how markets are reacting to